Last edition
News about "antibody discovery platform"
Nona Biosciences Signs License Deal with AstraZeneca for Monoclonal Antibody Development
Nona Biosciences has signed a license deal with AstraZeneca for preclinical monoclonal antibodies that will be used to create targeted therapies in oncology.
Antibody Discovery Platform | 27/05/2024 | By Aishwarya | 145
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members